LivaNova PLC announced that its Board of Directors named Vladimir A. Makatsaria as the company?s member of the Board of Directors, effective March 1, 2024. Makatsaria most recently served as Company Group Chairman at Johnson & Johnson MedTech. Makatsaria will succeed Kozy, who has served as Interim CEO since April 2023.

Kozy will continue in his role as LivaNova Board Chair. Makatsaria?s nearly 30-year career has been in healthcare with executive leadership roles at Johnson & Johnson, spanning across various technologies and geographies. He has served as Chairman of the Asia Pacific Medical Technology Association (APACMed) and as an Advisory Board Member to Singapore Management University.

Makatsaria holds a Bachelor of Arts in Physiology, a Master of Healthcare Administration and a Master of Business Administration from the University of Minnesota.